Web1 hour ago · Rhys McClenaghan has won gold medal in the pommel horse event at the European Artistic Gymnastics Championships in Antalya, Turkey. The Irish gymnast had topped qualifying and was first out, his ... WebApr 10, 2024 · Phesgo 1,200 Mg-600 Mg-30,000 Unit/15 Ml Subcutaneous Solution Antineoplastic - EGF Receptor 2 (HER2) Subdomain II Blocker 0 rating rating ratings
ANHANG I ZUSAMMENFASSUNG DER MERKMALE …
WebMar 1, 2024 · PHESGO may cause heart problems, including those without symptoms (such as reduced heart function) and those with symptoms (such as congestive heart failure). Your health professional may run tests to monitor your heart function before and during treatment with PHESGO. Based on test results your doctor may hold or discontinue treatment with … WebWhat does PHESGO treat? PHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for:. use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or … speed rating 94h vs 94v
Subcutaneous Trastuzumab and Pertuzumab (Phesgo®)
Web600 mg pertuzumab, 600 mg trastuzumab, 20,000 units hyaluronidase per 10 mL supplied in a single-dose, ready-to-use vial. Administer subcutaneously over approximately 5 minutes at a rate of no more than 2 mL/min. Observe for hypersensitivity or administration-related reactions: minimum of 15 minutes*. NDC: 50242-260-01. WebAug 25, 2024 · The initial dose of Phesgo™ is 1,200 mg pertuzumab, 600 mg trastuzumab, and 30,000 units hyaluronidase administered subcutaneously over approximately 8 minutes, followed every 3 weeks by a dose of 600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase administered subcutaneously over approximately 5 minutes ... WebSMC No. SMC2364. Pertuzumab/trastuzumab (Phesgo®) used in combination with chemotherapy for the treatment of adults with HER2-positive early stage breast cancer or in combination with docetaxel for the treatment of adults with HER2-positive metastatic or locally recurrent unresectable breast cancer (July 2024) Recommended with restrictions. speed rating discount tire